PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-24.21%
Negative revenue growth while EXP stands at 22.92%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-24.21%
Negative gross profit growth while EXP is at 44.08%. Joel Greenblatt would examine cost competitiveness or demand decline.
143.23%
EBIT growth above 1.5x EXP's 58.15%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
143.23%
Operating income growth above 1.5x EXP's 58.15%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-72.54%
Negative net income growth while EXP stands at 44.08%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
308.96%
10Y revenue/share CAGR 1.25-1.5x EXP's 273.82%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
68.07%
5Y revenue/share CAGR similar to EXP's 63.28%. Walter Schloss might see both companies benefiting from the same mid-term trends.
60.93%
3Y revenue/share CAGR above 1.5x EXP's 26.11%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
234.86%
Below 50% of EXP's 493.87%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
11.62%
5Y net income/share CAGR above 1.5x EXP's 7.51%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
95.50%
Below 50% of EXP's 319.28%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.